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Edited by Jesus AvilaAbstract Endocytic pathway abnormalities were previously ob-
served in brains aﬀected with Alzheimer’s disease (AD). To clar-
ify the pathological relevance of these abnormalities to assembly
of amyloid b-protein (Ab), we treated PC12 cells with chloro-
quine, which potently perturbs membrane traﬃcking from endo-
somes to lysosomes. Chloroquine treatment induced
accumulation of GM1 ganglioside (GM1) in Rab5-positive en-
larged early endosomes and on the cell surface. Notably, an in-
crease in GM1 level on the cell surface was suﬃcient to induce
Ab assembly. Our results suggest that endocytic pathway abnor-
malities in AD brain induce GM1 accumulation on the cell sur-
face, leading to amyloid ﬁbril formation in brain.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The extracellular deposition of amyloid b-protein (Ab) is a
pathological hallmark of Alzheimer’s disease (AD), however,
it remains to be clariﬁed how soluble Ab starts to assemble
in the brain. We previously identiﬁed a unique Ab species char-
acterized by its binding to GM1 ganglioside (GM1) in brains
exhibiting early pathological changes of AD [1]. On the basis
of the molecular characteristics of GM1-bound Ab (GAb),
we hypothesized that GAb acts as a seed for Ab ﬁbrillogenesis
in AD brain [1]. Despite accumulating evidence that suggests
the pathological implication of GAb [for review, see Ref.
[2]], our hypothesis has been challenged by the simple question
of how GAb is formed in the brain. In this context, we have
recently found that GM1 level increases in the membrane
microdomains of synaptosomes prepared from aged human
apolipoprotein E4 (apoE4)-knock-in mouse brains [3]. This re-
sult suggests that GM1 accumulation in neuronal membranes
underlies Ab assembly in AD brain. Importantly, this possibil-Abbreviations: AD, Alzheimer’s disease; Ab, amyloid b-protein; GM1,
GM1 ganglioside; GAb, GM1-bound Ab; APP, amyloid precursor
protein; apoE, apolipoprotein E; CTB, cholera toxin B subunit; HRP,
horseradish peroxidase; NGF, nerve growth factor
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doi:10.1016/j.febslet.2006.11.072ity has recently been supported by studies of AD brains [4,5].
The next issue that must be addressed is how the expression
and/or traﬃcking of GM1 is altered, leading to GM1 accumu-
lation in neuronal membranes in AD brain. Regarding cellular
AD pathology, it is noteworthy that endocytic pathway abnor-
malities, including the enlargement of early endosomes and the
upregulation of Rab5 (a small GTPase associated with early
endosomes) are observed in neurons of AD brains [6]. In this
study, we aimed to clarify the pathological relevance of endo-
cytic pathway abnormalities to Ab assembly using PC12 cells
treated with chloroquine which potently perturbs membrane
traﬃcking from endosomes to lysosomes [7].2. Materials and methods
2.1. Materials
Chloroquine, cholera toxin B subunit (CTB), and horseradish perox-
idase (HRP)-conjugated CTB (CTB-HRP) were obtained from Sigma
(St. Louis, MO). Alexa Fluor 594-coupled CTB (CTB-AF) was pur-
chased from Invitrogen (Carsbad, CA). Antibodies speciﬁc to Rab4,
Rab5 and Rab7 were purchased from Santa Cruz Biotechnology (San-
ta Cruz, CA). An anti-actin monoclonal antibody, the anti-Ab mono-
clonal antibody 6E10 and the anti-amyloid precursor protein
monoclonal antibody 22C11 were purchased from Sigma, Signet Lab-
oratories (Dedham, MA) and Chemicon International (Temecula,
CA), respectively. Synthetic Ab1-40 (Ab) was purchased from Peptide
Institute (Osaka, Japan).2.2. Cell culture
PC12 cells were cultured in Dulbecco’s modiﬁed Eagle’s medium
(DMEM, Invitrogen) supplemented with 5% fetal bovine serum and
10% horse serum. For nerve growth factor (NGF)-induced diﬀerentia-
tion, PC12 cells were seeded on poly-L lysine-coated dishes or chamber
slides (Nunc, Roskilde, Denmark) at a density of 2 · 104 cells/cm2 and
cultured in DMEM containing 100 ng/ml NGF (Almone Labs., Jeru-
salem, Israel). The medium and NGF were replenished every 2 days.
After 6 days, the cells were pharmacologically treated with chloroquine
and other reagents.2.3. SDS–PAGE and Western blotting
Cells were lysed in Triton X-100-containing Tris buﬀer [50 mM Tris–
HCl (pH 7.4), 150 mM NaCl, 1 mM EGTA, 1% Triton X-100, Com-
plete protease inhibitor cocktail (Roche Molecular Biochemicals,
Penzberg, Germany)]. Cell extracts were centrifuged at 13000 · g for
2 min. Then, the obtained supernatants were solubilized with sodium
dodecyl sulfate (SDS) sample buﬀer. The samples were separated on
a 4–20% polyacrylamide gel, and then electrotransferred to nitrocellu-
lose membranes (for GM1 and Ab) or polyvinylidene diﬂuoride mem-
branes (for other proteins). The blots were probed with CTB-HRP or
with primary antibodies followed by HRP-coupled secondary antibod-
ies.blished by Elsevier B.V. All rights reserved.
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To examine the intracellular distribution of GM1 and the endosome-
binding proteins Rab5 and Rab7, PC12 cells, which had been treated
with 1 lM chloroquine for 5 days, were ﬁxed with 3% paraformalde-
hyde/0.5% glutaraldehyde for 30 min at 4 C, and then permeabilized
with 0.01% Triton X-100 for 5 min at 4 C. After blocking with 5%
BSA, the cells were incubated with the anti-Rab5 or anti-Rab7 anti-
body overnight at 4 C. Then cells were probed with the 0.1 mg/ml
CTB-AF and anti-rabbit IgG-AF594 for 2 h at 4 C. For detection
of cell-surface GM1, the cells were incubated with 0.05 mg/ml CTB-
AF in HEPES-buﬀered DMEM at 4 C for 5 min and ﬁxed with 4%
paraformaldehyde in PBS at room temperature. Stained cells were ob-
served under a microscope equipped with a laser-scanning confocal
imaging system, LSM510 (Carl Zeiss, Oberkochen, Germany).
2.5. Evaluation of Ab ﬁbrillogenesis in cultures and thioﬂavin-S staining
Cells which had been treated with 1 lM chloroquine for 4 days were
incubated with 10 lM seed-free Ab, which had been prepared as pre-
viously reported [8], for 24 h at 37 C, and centrifuged at 540000 · g
for 15 min. The obtained precipitates were subjected Western blotting
following solubilization in formic acid. Thioﬂavin-S (ThS) staining was
performed according to a method previously reported [9].3. Results
3.1. Eﬀect of chloroquine treatment on cellular GM1 levels
The GM1 level in the cell lysates markedly increased in
chloroquine-dose-dependent and time-dependent manners
(Fig. 1A). To investigate the mechanism underlying chloro-
quine-induced GM1 accumulation, we performed Western
blotting of the cell lysates using antibodies speciﬁc to amyloid
precursor protein (APP), which is endocytosed via a clathrin-
dependent pathway [10]. Treatment with 10 lM chloroquine
increased GM1 level whereas APP level remained unchanged
(Fig. 1B). In contrast, treatment with 100 lM chloroquine de-Fig. 1. Eﬀect of chloroquine treatment on GM1 level in PC12 cells.
(A) PC12 cells were treated with chloroquine at the indicated
concentrations for various durations. The lysates of treated cells were
electrophoresed. The blots were reacted with CTB-HRP. (B) PC12 cells
were treated with chloroquine at the indicated concentrations for 12 h.
GM1 and APP were detected by Western blotting using CTB-HRP
and an antibody speciﬁc to the N-terminus of APP, respectively. (C)
PC12 cells were treated with ammonium chloride at the indicated
concentrations for 5 days.creased GM1 level but markedly increased APP level (Fig. 1B).
We treated the cells with ammonium chloride, another weak
base similar to chloroquine. Treatment with ammonium chlo-
ride also induced GM1 accumulation (Fig. 1C). We monitored
cell viability using release assay of lactate dehydrogenase. No
signiﬁcant level of cell death was observed under these condi-
tions (data not shown).
3.2. Rab5 accumulation in chloroquine-treated cells
To examine the eﬀect of chloroquine treatment on endocytic
pathway compartments, we performed Western blotting of ly-
sates of the cells, which had been treated with 1 lM chloro-
quine for 5 days, using antibodies speciﬁc to Rab5, Rab7
and Rab4, which are proteins speciﬁcally associated with early
endosomes, late endosomes and recycling vesicles, respectively.
The levels of Rab5 and Rab4 signiﬁcantly increased following
chloroquine treatment (Fig. 2A and B).
3.3. GM1 accumulation in early endosomes and on surface of
chloroquine-treated cells
We explored the cellular sites where GM1 accumulation oc-
curred. We treated cells with 1 lM chloroquine for 5 days. In
the immunocytochemistry, the level of GM1 stained with
CTB-AF following permeabilization pretreatment markedly
increased in some organelles and on plasma membranes
(Fig. 3A). Double staining with CTB-AF and an antibodyFig. 2. Eﬀect of chloroquine treatment on the levels of endosome-
binding proteins in PC12 cells. PC12 cells were treated with 1 lM
chloroquine for 5 days. (A) Cell lysates were subjected to Western
blotting using CTB-HRP and speciﬁc antibodies. (B) The intensities of
the bands were determined by quantitative densitoscanning. Each
column represents the average ±1 S.D. of three values as percent of
control values obtained from untreated PC12 cells. () and (+)
indicate without and with chloroquine, respectively. *P < 0.005 and
**P < 0.05 (two-tailed Student’s t-test).
Fig. 3. GM1 accumulation in early endosomes and on surface of
chloroquine-treated PC12 cells. PC12 cells were treated with 1 lM
chloroquine for 5 days. (A) Images of ﬂuorescence staining of chloro-
quine-treated or untreated PC12 cells with CTB-AF following perme-
abilization pretreatment for detecting GM1 (green) and antibodies
speciﬁc to Rab5 or Rab7 (red). Arrows indicate enlarged vesicles in
which GM1 and Rab5 colocalized in chloroquine-treated cells. Bar,
5 lm. (B) PC12 cells, which had been treated with 1 lM chloroquine
for 5 days, were incubated with CTB-AF at 4 C prior to ﬁxation. Bar,
20 lm.
Fig. 4. Accelerated amyloid ﬁbril formation from soluble Ab in
cloroquine-treated PC12 cell culture. (A) Insoluble Ab formed in the
PC12 cell culture, which were incubated with soluble Ab at 1–50 lM
for 24 h following treatment with (+) or without () 1 lM chloroquine
for 4 days, was subjected to Western blot analysis following solubi-
lization in formic acid. The blot was reacted with a monoclonal
antibody against Ab. (B) Suppression of amyloid ﬁbril formation in
the culture by cotreatment with CTB and 4396C, an antibody speciﬁc
to GAb [8]. PC12 cells were incubated with Ab at 10 lM for 24 h with
or without CTB or 4396C at the indicated concentrations after prior
treatment with 1 lM chloroquine for 4 days. Insoluble Ab formed in
the cultures was detected as indicated in (A). (C) Amyloid ﬁbrils
formed in the PC12 cell culture, which was incubated with Ab at
10 lM for 2 h after pretreatment with 1 lM chloroquine for 4 days,
were visualized by ThS staining. Arrows indicate ThS-positive spots.
Bar, 20 lm.
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Rab5 were markedly enlarged, which apparently agrees with
previously reported enlarged early endosomes in neurons of
AD brains [6] (Fig. 3A). We also performed double staining
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colocalized spot was observed (Fig. 3A). To conﬁrm GM1
accumulation on the surface of cells, we also incubated the
cells with CTB-AF prior to ﬁxation at 4 C to prevent the
internalization of CTB-AF from the cell surface. Compared
with untreated cells, chloroquine-treated cells showed a
marked increase in the level of CTB-AF bound to their surface
(Fig. 3B).
3.4. Accelerated Ab ﬁbrillogenesis in chloroquine-treated cell
cultures
We examined whether accumulated GM1 on the surface of
PC12 cells can potently induce the assembly of soluble exoge-
nous Ab. We performed Western blotting of precipitates of the
cultured cells, which had been treated with 1 lM chloroquine
for 4 days, following incubation with Ab for 24 h at ﬁnal con-
centrations of 1–50 lM. The level of insoluble, assembled Ab
signiﬁcantly increased in the cultures treated with chloroquine
compared with that in nontreated cultures (Fig. 4A). Impor-
tantly, the level of insoluble Ab signiﬁcantly decreased in the
presence of CTB or 4396C, an antibody speciﬁc to GAb
(Fig. 4B). Consistent with the result of Western blotting, the
signiﬁcant level of ThS ﬂuorescence intensity was observed
only on the surface of the cells, which had been treated with
chloroquine (Fig. 4C).4. Discussion
GM1 molecules on plasma membranes are endocytosed and
transported to lysosomes along early and late endosomes, and
there, the ﬁrst hydrolysis catalyzed by b-galactosidase occurs
[11,12]. However, little is known about how the endocytosis
of GM1 is regulated. In this study, the treatment of PC12 cells
with chloroquine at low lM concentrations induced marked
GM1 accumulation whereas that at high lM concentration,
which is required for the inhibition of lysosomal activity [13],
induced the GM1 disappearance.
It remains to be clariﬁed how GM1 disappearance was in-
duced by chloroquine at a high lM concentration; however,
possible explanations for GM1 accumulation by a chloroquine
at low lM concentrations may be as follows; ﬁrst, intralysos-
omal GM1 degradation may be inhibited by chloroquine; sec-
ond, GM1 traﬃcking through endocytic pathway may be
perturbed by the chloroquine-induced impairment of the acid-
iﬁcation of endocytic pathway compartments. Unlike GM1,
accumulation of APP, which is degraded in lysosomes
[14,15], was only induced by chloroquine at a high lM concen-
tration as previously reported [16]. This result suggests that
chloroquine treatment of cells with chloroquine at low concen-
trations is insuﬃcient to inhibit lysosomal activity. Thus, we
favor the second possibility. In this context, it is noteworthy
that a recent study revealed the crucial role of endosomal acid-
iﬁcation in regulation of endocytic pathway through modula-
tion of the interaction of V-ATPase with Arf6 and ARNO,
which are small GTPase molecule and its cognate GDP/GTP
exchange factor, respectively [17]. Thus, it is assumed that im-
paired acidiﬁcation by chloroquine induced GM1 stagnation
in early endosomes and on the cell surface. Taking account
of upregulation of Rab4, it is also possible to assume that a
population of GM1 molecules stagnated in early endosomes
was transported to the cell surface through recycling pathway.One of the unexpected observation in this study is that GM1
was readily accumulated in early endosomes and on the cell
surface without the apparent accumulation of APP, that shall
be endocytosed via a clathrin-dependent pathway [10].
Although further studies are needed to conclude, GM1 may
be endocytosed and sorted into a population of early endo-
somes diﬀerent from those for APP. The following is evidence
in favor of this possibility: ﬁrst, CTB is endocytosed via a
clathrin-independent pathway [18]; and second, there are dis-
tinct groups of early endosomes with diﬀerent sorting func-
tions [19].
Overall, our results may imply that endocytic pathway
abnormalities in neurons cause GM1 accumulation on the neu-
ronal surface, leading to extraneuronal Ab ﬁbrillogenesis. A
challenge for future studies is to determine how endocytosis
and traﬃcking of GM1 are regulated in neurons and how these
are altered in AD brain by risk factors for AD development
such as aging and apoE4 expression.
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